loader
Please Wait
Applying Filters...

Looking for Fillers, Diluents & Binders? Find Fillers, Diluents & Binders Agents used in Boceprevir to address drug delivery challenges on PharmaCompass.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 16DKSH

02 3Jai Radhe Sales

03 2Boai NKY Pharmaceuticals Ltd

04 14Gangwal Healthcare

05 1Nanjing Well Pharmaceutical

06 6Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

07 8BASF

08 4DFE Pharma

09 4Gangwal Chemicals

10 21Kerry

11 10Microlex e.U

12 3Novo Excipients

13 3Pharmatrans-Sanaq

14 8Pluviaendo

15 2Prachin Chemical

16 4Roquette

17 2Shanghai Shenmei Pharmaceutical Technology Co., Ltd

18 7Sigachi Industries

19 3Ulanqab Kema New Material

20 4Vasa Pharmachem

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Grade : Parenteral, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Grade : Oral (Pharma Grade)

Brand Name : KoVidone® K25

Excipient Details : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Grade : Oral (Pharma Grade)

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBoai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

Ingredient(s) : Polyvinylpyrrolidone

Dosage Form : Capsule, Tablet

Category : Fillers, Diluents & Binders

Brand : KOVIDONE® K25

Applications : KoVidone® K25 is used as a low viscosity wet binder in solid dosage forms such as capsules and tablets.

Pharmacopoeia Ref : USP/NF, EP, JP, KP, IP, BP

Technical Specs : NA

Grade : Oral (Pharma Grade)

arrow

06

arrow
2024 ACI Convention
Not Confirmed
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Grade : Parenteral

Brand Name : Lactose Monohydrate

Excipient Details : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

Grade : Parenteral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothNanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Ingredient(s) : Lactose Monohydrate

Dosage Form : Injectable / Parenteral

Category : Parenteral

Brand : LACTOSE MONOHYDRATE

Applications : Lactose monohydrate is used as a diluent in inhalation and lyophilized preparations.

Pharmacopoeia Ref : ChP/USP/EP/JP

Technical Specs : NA

Grade : Parenteral

arrow

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Grade : Parenteral, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Brand : PIG SKIN GELATIN 140B 20M

Applications : Pig skin gelatin 140B 20M is used as a binder and filler in pellets, granules, capsules, and tablets and as a stabilizer in parenteral products.

Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

Technical Specs : N/A

Grade : Parenteral, Oral

arrow

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Grade : Parenteral, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Brand : GELATIN BOVINE 140B 6M

Applications : Gelatin bovine 140B 6M is used as a stabilizer in parenteral drug products and as a binder and filler in capsules, tablets, granules, and pellets.

Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

Technical Specs : N/A

Grade : Parenteral, Oral

arrow

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : STARLOSE®

Applications : STARLOSE is used as a diluent, binder, directly compressible (DC), and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : IP/EP/USP-NF/IH

Technical Specs : NA

Grade : Oral

arrow

10

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Grade : Parenteral, Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothDKSH is your trusted partner for companies looking to grow their business in Asia & beyond.

Brand : GELITA

Applications : Gelita RXL R² 115B BB TB Ph is used as a stabilizer in parenteral formulations and as a filler and binder in tablets, capsules, granules, and pellets.

Pharmacopoeia Ref : CEP, GMP, EP, USP/NF

Technical Specs : N/A

Grade : Parenteral, Oral

arrow

11

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

Brand Name : Microlose™ M60 P60

Excipient Details : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

Grade : Oral

arrow
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : MICROLOSE™ M60 P60

Applications : Microlose M60 P60 is used as a filler, binder, directly compressible, and co-processed excipient in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Lactose Monohydrate – 40%, Microcrystalline cellulose – 60%

Grade : Oral

arrow

12

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

13

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Brand : DICOM-DC® S604

Applications : DiCOM-DC S604 is used as a DC co-processed excipient with a combination of various polymers that act as fillers and binders in tablets and capsules.

Pharmacopoeia Ref : In-house

Technical Specs : Polyvinyl Pyrrolidone 97% & 93%

Grade : Oral

arrow

14

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

Grade : Oral

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothGangwal Healthcare is powered by innovation, driving health, wellness & healing.

15

arrow
2024 ACI Convention
Not Confirmed

16

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

18

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-101

Excipient Details : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-101

Applications : Most popular excipient for the production of tablets and capsules. Offering an efficient and low dosage in capsules.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-10 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

20

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

24

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-102

Excipient Details : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-102

Applications : Higher specific surface area and a smaller median particle size. This product is preferred for more critical and very fine herbal formulations.

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-8-12 m2/g; Particle Size-5-9 µm

Grade : Oral

arrow
blank

25

arrow
2024 ACI Convention
Not Confirmed

26

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

27

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

28

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pharmacel 101

Excipient Details : Pharmacel® 101 is a pharmaceutical excipient that acts as a pharmaceutical binder & filler for wet and dry granulation as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...

Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57

Grade : Oral

arrow

Brand : PHARMACEL 101

Applications : Pharmacel® 101 is a pharmaceutical excipient that acts as a pharmaceutical binder & filler for wet and dry granulation as it ensures uniform granulation and drying processes. It also provides excellent compaction and disintegration.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., JP, IP

Technical Specs : Density- Tapped density- 440 g/l, Bulk density- 280 g/l; Particle size- D10- 25 ?m, D50- 60 ?m, D90- 20 ?m; Hausner ratio-1,57

Grade : Oral

arrow
blank

29

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Microlex® MS-103

Excipient Details : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow

Brand : MICROLEX® MS-103

Applications : Suitable for combination with the favourable crystalline. Designed for special formulations, as low and stable viscosity is required for tablet coatings, Supports a lower dissolution profile

Pharmacopoeia Ref : Monograph- Ph.Eur, USP/NF

Technical Specs : Specific Surface Area-6-8 m2/g; Particle Size-7-11 µm

Grade : Oral

arrow
blank

30

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Pharmatose 200M

Excipient Details : Pharmatose® 200M is a pharmaceutical excipient that is a highly consistent monohydrate lactose which delivers good compaction properties. This lactose type is typically used in oral dosage forms like tablets and pharmaceutical capsules.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...

Technical Specs : Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46

Grade : Oral

arrow

Brand : PHARMATOSE 200M

Applications : Pharmatose® 200M is a pharmaceutical excipient that is a highly consistent monohydrate lactose which delivers good compaction properties. This lactose type is typically used in oral dosage forms like tablets and pharmaceutical capsules.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph

Technical Specs : Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle size- D10- 5 ?m, D50- 40 ?m, D90- 120 ?m; Hausner ratio- 1,46

Grade : Oral

arrow
blank

31

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

32

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

34

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand Name : Supertab 11SD

Excipient Details : SuperTab® 11SD is a pharmaceutical excipient which is a highly consistent, spray-dried lactose enabling efficient tableting by offering free flow properties. It also offers excellent compaction properties and content uniformity.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...

Technical Specs : Density- Tapped density- 716 g/l, Bulk density- 599 g/l; Particle size- D10-50 ?m, D50- 120 ?m, D90- 220 ?m; Hausner ratio-1,2

Grade : Oral

arrow

Brand : SUPERTAB 11SD

Applications : SuperTab® 11SD is a pharmaceutical excipient which is a highly consistent, spray-dried lactose enabling efficient tableting by offering free flow properties. It also offers excellent compaction properties and content uniformity.

Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., JP lactose monohydrate monograph

Technical Specs : Density- Tapped density- 716 g/l, Bulk density- 599 g/l; Particle size- D10-50 ?m, D50- 120 ?m, D90- 220 ?m; Hausner ratio-1,2

Grade : Oral

arrow
blank

35

arrow
2024 ACI Convention
Not Confirmed

36

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

37

arrow
2024 ACI Convention
Not Confirmed

42

arrow
2024 ACI Convention
Not Confirmed

56

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Brand : F-MELT TYPE C

Applications : F-Melt Type C is a pharmaceutical excipient used in oral dosage forms like orally disintegrating tablets, sachets, dispersible tablets, chewable tablets and sublingual tablets.

Pharmacopoeia Ref : Conforms to Japanese Pharmaceutical Excipients. All components meet USP-NF, JP, EP. US DMF Type IV filed.

Technical Specs : Not Available

Grade : Oral

arrow
blank

58

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed
blank

59

arrow
2024 ACI Convention
Not Confirmed

60

arrow
2024 ACI Convention
Not Confirmed